← FDA DRUG APPROVALS

FDA ANDA · ANDA065226

CEFAZOLIN SODIUM

Sponsor: HOSPIRA INC

APPLICATION
ANDA065226
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-21
LATEST ACTION
2014-05-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2014-05-05Labeling · Supplement 11 · standardAP
2009-09-30Labeling · Supplement 7AP
2009-01-15Labeling · Supplement 5AP
2007-10-26Labeling · Supplement 3AP
2005-04-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →